 To assess the safety of bevacizumab in combination with verteporfin PDT reduced fluence: 300 mWcm2 as compared to bevacizumab in combination with verteporfin PDT standard fluence: 600 mWcm2 in patients whose neovascular CNV lesions containing 50 blood. 